Evidence map›Paper›PMID 8855302›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1996

Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells.

M Taniguchi, H Koseki, T Tokuhisa, K Masuda, H Sato, E Kondo, T Kawano, J Cui, A Perkes, S Koyasu and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 101 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Regulatory T cells induce CD4Cancer immunology, immunotherapy : CII · 2019
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  16. Antitumor Responses of Invariant Natural Killer T Cells.Journal of immunology research · 2015
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

M TaniguchiDivision of Molecular Immunology, Chiba University, Japan.
H Koseki
T Tokuhisa
K Masuda
H Sato
E Kondo
T Kawano
J Cui
A Perkes
S Koyasu
Y Makino
Chiba University · JPMassachusetts Institute of Technology · US

Funding

FC-EPSILON-RI-GAMMA IN T CELL RECEPTORS ON LGL--FUNCTIONR01AI033017 · NIAID · DANA-FARBER CANCER INSTITUTE · PI REINHERZ, ELLIS L · 1994 to 1996
–
NIAID NIH HHS R01AI33017
6 · The paper itself

Abstract

NK1.1+ T [natural killer (NK) T] cells express an invariant T cell antigen receptor alpha chain (TCR alpha) encoded by V alpha 14 and J alpha 281 segments in association with a limited number of V betas, predominantly V beta 8.2. Expression of the invariant V alpha 14/J alpha 281, but not V alpha 1, TCR in transgenic mice lacking endogenous TCR alpha expression blocks the development of conventional T alpha beta cells and leads to the preferential development of V alpha 14 NK T cells, suggesting a prerequisite role of invariant V alpha 14 TCR in NK T cell development. In V beta 8.2 but not B beta 3 transgenic mice, two NK T cells with different CD3 epsilon expressions, CD3 epsilon(dim) and CD3 epsilon(high), can be identified. CD3 epsilon(high) NK T cells express surface V alpha 14/V beta 8 TCR, indicating a mature cell type, whereas CD3 epsilon(dim) NK T cells express V beta 8 without V alpha 14 TCR and no significant CD3 epsilon expression (CD3 epsilon(dim)) on the cell surface. However, the latter are positive for recombination activating gene (RAG-1 and RAG-2) mRNA, which are only expressed in the precursor or immature T cell lineage, and also possess CD3 epsilon mRNA in their cytoplasm, suggesting that CD3 epsilon(dim) NK T cells are the precursor of V alpha 14 NK T cells.

Indexed as

DNA-Binding ProteinsHomeodomain ProteinsAnimalsGene Expression Regulation, DevelopmentalHematopoiesisKiller Cells, NaturalLymphocyte SubsetsMiceMice, Inbred C57BLMice, TransgenicProteinsReceptors, Antigen, T-Cell, alpha-betaRNA, MessengerT-Lymphocyte SubsetsDNA-Binding ProteinsHomeodomain ProteinsProteinsRAG-1 proteinRag2 protein, mouseReceptors, Antigen, T-Cell, alpha-betaRNA, MessengerV(D)J recombination activating protein 2

Identifiers

PMID8855302
PMCPMC38277
OpenAlexW2118756186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.